| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 02/12/1998 | WO1998005635A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | WO1998005353A1 hCG AND DERIVATIVES AS MATRIX METALLOPROTEASES INHIBITORS |
| 02/12/1998 | WO1998005338A2 Use of a dehydroepiandrosterone derivative for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue |
| 02/12/1998 | CA2263154A1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 02/12/1998 | CA2262401A1 Secreted proteins and polynucleotides encoding them |
| 02/11/1998 | EP0822829A1 Use of glial neurotrophic factor (gdnf) for treatment of hearing disorders |
| 02/11/1998 | EP0822822A1 Controlled release of miotic and mydriatic drugs in the anterior chamber |
| 02/11/1998 | CN1173170A Matrix metalloprotease inhibitors |
| 02/11/1998 | CN1172662A Powder for treating tinnitus |
| 02/10/1998 | US5716979 Tachykinin antagonists |
| 02/10/1998 | US5716966 7-(2-imidazolinylamino)quinoline compounds useful as alpha-2 adrenoceptor agonists |
| 02/10/1998 | US5716961 Treatment of tinnitus using neuroprotective agents |
| 02/10/1998 | US5716955 Cytokine inhibitor |
| 02/10/1998 | US5716952 Topical application |
| 02/10/1998 | US5716936 Pyrrolidine derivatives for the treatment of cholecystokinine and gastrine-related disorders |
| 02/10/1998 | US5716632 Administering n-substituted 2-(1h)pyridones or 3-(1h)pyridones |
| 02/10/1998 | US5716624 Polyaromatic propynyl compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 02/10/1998 | US5716617 Concurrent purification of mixture |
| 02/05/1998 | WO1998004131A1 Methods of treatment of eye trauma and disorders |
| 02/05/1998 | WO1997038084A3 Polynucleotides derived from a pbmc cdna library encoding secreted proteins |
| 02/05/1998 | CA2261765A1 Methods of treatment of eye trauma and disorders |
| 02/04/1998 | EP0822186A2 L-tert-leucine-2-pyridylamide |
| 02/04/1998 | EP0821669A1 Hydroxamic and carboxylic acids as metalloprotease inhibitors |
| 02/04/1998 | EP0821668A1 Derivatives of succinamide and their use as metalloproteinase inhibitor |
| 02/04/1998 | EP0821666A1 Derivatives of succinamide and their use as metalloproteinase inhibitors |
| 02/04/1998 | CN1172483A Substituted heterocyclic compounds, preparation method thereof and pharmaceutical compositions containing same |
| 02/03/1998 | US5714621 1,3-benzodioxole and 1,2-dialkoxybenzene derivatives as ocular hypotensive agents |
| 02/03/1998 | US5714514 2-Cyano-3-mercaptocrotonamides |
| 02/03/1998 | US5714487 2,7-substituted octahydro-pyrrolo 1,2-a!pyrazine derivatives |
| 02/03/1998 | US5714486 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 02/03/1998 | US5714484 α-(1,3-dicarbonylenol ether) methyl ketones as cysteine protease inhibitors |
| 02/03/1998 | US5714463 Use of growth factor and antimetabolite combination to prevent or retard fistula closure following glaucoma filtration surgery |
| 02/03/1998 | US5714381 DNA encoding human alpha 1 adrenergic receptors and uses thereof |
| 02/03/1998 | CA2011956C Sodium hyaluronate composition |
| 02/03/1998 | CA1339660C Derivatives of cyclohexane |
| 01/29/1998 | WO1998003484A1 Substituted pyridines as selective cyclooxygenase-2 inhibitors |
| 01/29/1998 | WO1998003166A1 Thiol sulfonamide metalloprotease inhibitors |
| 01/29/1998 | WO1998003162A1 Medicinal compositions |
| 01/29/1998 | CA2260860A1 Thiol sulfonamide metalloprotease inhibitors |
| 01/28/1998 | EP0820991A2 Cycloalkyl derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820988A2 Imino derivatives as bone resorption inhibitors and vitronectin receptor antagonists |
| 01/28/1998 | EP0820467A1 Methods of treating disorders of the eye |
| 01/28/1998 | EP0820445A1 Inhibitors of farnesyl-protein transferase |
| 01/28/1998 | EP0820441A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS |
| 01/28/1998 | EP0820286A1 Treatment for ocular inflammation |
| 01/28/1998 | EP0489779B1 Ophthalmic composition |
| 01/28/1998 | CN1171780A Hydroxamic acid-containing inhibitors of matrix metalloproteases |
| 01/28/1998 | CN1171736A Matrix type patch preparations |
| 01/27/1998 | US5712297 Piperdine compounds and their preparation and use |
| 01/27/1998 | US5712296 Substituted pyridines and 2-oxo-1,2-dihydropyridines |
| 01/27/1998 | US5712291 Methods and compositions for inhibition of angiogenesis |
| 01/27/1998 | US5712273 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds |
| 01/24/1998 | CA2211148A1 Novel imino derivatives as inhibitors of bone resorption and vitronectin receptor antagonists |
| 01/22/1998 | WO1998002156A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for lowering intraocular pressure |
| 01/22/1998 | WO1998002155A1 2-phenyl-3-azoylbenzothiophene for lowering intraocular pressure |
| 01/22/1998 | WO1997035591A3 Method of treating ciliary dyskinesia with uridine triphosphates and related compounds |
| 01/21/1998 | EP0819125A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/21/1998 | EP0819003A1 A method for the treatment of macular degeneration |
| 01/21/1998 | EP0701443B1 Terfenadine metabolites and their optically pure isomers for treating allergic disorders |
| 01/21/1998 | CN1171119A Binding agents for curing inflammatory, autoimmune or allergic diseases |
| 01/21/1998 | CN1171107A Esters and amides of non-steroidal anti-inflammatory carboxylic acids which may be used as anti-oxidants, 5-lipoxygenase inhibotors and non-steroidal anti-inflammatory products |
| 01/20/1998 | US5710182 Topical solution of active agent, hydrophilic polymer, salt, wetting agent, preservative, water |
| 01/20/1998 | US5710139 Heterocyclic compounds |
| 01/20/1998 | US5710136 Inhibition of neovascularization using VEGF-specific oligonucleotides |
| 01/20/1998 | US5709867 Polyaromatic amide compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/15/1998 | WO1998001444A1 BENZO[g]QUINOLINE DERIVATIVES |
| 01/15/1998 | WO1998001124A2 Pharmaceutical preparation containing nimesulide for topical use |
| 01/14/1998 | EP0817648A1 Vascular endothelial cell growth factor antagonists |
| 01/14/1998 | EP0817628A2 Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules |
| 01/14/1998 | EP0817610A1 Sterile ophthalmological gel preparation applicable in drops and process for producing it |
| 01/14/1998 | EP0651738B1 Natural amino acid derivatives as metalloproteinase inhibitors |
| 01/14/1998 | CN1169861A Health-care tea for preventing and curing eye diseases and preparation method |
| 01/13/1998 | US5708024 Salts of 2- (2,6-dichlorophenyl)amine!phenylacetoxyacetic acid with organic basic cations |
| 01/13/1998 | US5707991 N-acylpyrrolidines and medicaments for the treatment or prevention of disorders linked to CKK and to gastrin |
| 01/13/1998 | US5707829 DNA sequences and secreted proteins encoded thereby |
| 01/13/1998 | US5707627 Methods and compositions for the direct concentrated delivery of passive immunity |
| 01/08/1998 | WO1997041824A3 Antiangiogenic peptides derived from plasminogen |
| 01/07/1998 | EP0816502A2 Mur A-1, an UDP-N-acetylglucosamine enolpyruvyl-transferase from Streptococcus pneumoniae |
| 01/07/1998 | EP0816352A1 Bi-aryl heterocyclic compounds and their use in human or veterinary medicine and in cosmetics |
| 01/07/1998 | EP0815860A2 Terfenadine carboxylate and the treatment of allergic disorders |
| 01/07/1998 | EP0815237A1 Threonyl-trna synthetase of staphylococcus aureus |
| 01/07/1998 | EP0815232A1 Protein production and delivery |
| 01/07/1998 | EP0815218A2 Human vegf-specific antisense oligonucleotides |
| 01/07/1998 | EP0815115A1 Keratinocyte growth factor-2 |
| 01/07/1998 | EP0815112A1 Process for isolating galanthamine |
| 01/07/1998 | EP0700301A4 Peptides and compounds that bind to elam-1 |
| 01/07/1998 | EP0464175B1 Extracellular form of the human fibroblast growth factor receptor |
| 01/06/1998 | US5705658 Azido containing tetrahydro furan compounds |
| 01/06/1998 | US5705530 Side effect reduction; glaucoma treatment |
| 01/06/1998 | US5705510 Use of cabergoline and related ergoline derivatives for controlling intraocular pressure |
| 01/06/1998 | CA2084875C Procedure for the purification of hyaluronic acid and fraction of pure hyaluronic acid for ophthalmic use |
| 12/31/1997 | WO1997049827A2 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/31/1997 | WO1997049419A1 Ophthalmic drug compositions |
| 12/31/1997 | CN1168794A Method of reducing tissue damage associated with non-cardiac ischemia |
| 12/31/1997 | CA2259228A1 Adenoviral mediated gene transfer in adipocytes and related implants |
| 12/30/1997 | US5703106 Treating various cardiovascular, urogenital, brain disorders |
| 12/30/1997 | US5703077 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
| 12/30/1997 | US5703051 Therapeutic uses of melanin |
| 12/29/1997 | EP0813529A1 Arginine analogues having nitric oxide synthase inhibitor activity |
| 12/29/1997 | EP0771195A4 Method of inhibiting nitric oxide formation |